1. Incidence, clinical features and management of hypersensitivity reactions to chemotherapeutic drugs in children with cancer

   • Antonio Ruggiero
   • Silvia Triarico
   • Riccardo Riccardi

   Review Article 14 June 2013 Pages: 1739 - 1746

2. Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: a propensity score-matched cohort study

   • L. Frankenstein
   • H. A. Katus
   • on behalf of the Norwegian Heart Failure Registry steering committee

   Clinical Trial 07 June 2013 Pages: 1747 - 1755

   

3. Survey of users of TOPS, an internet-based system to prevent healthy subjects from over-volunteering for clinical trials

   • M. Boyce
   • M. Walther
   • S. Warrington

   Clinical Trial 07 June 2013 Pages: 1757 - 1760

4. Preladenant, a selective adenosine A_2A receptor antagonist, is not associated with QT/QTc prolongation

   • Z. Wang
   • F. Xuan
   • D. L. Cutler

   Clinical Trial 16 July 2013 Pages: 1761 - 1767

   

5. Cytochrome P450 oxidoreductase genetic polymorphisms A503V and rs2868177 do not significantly affect warfarin stable dosage in Han-Chinese patients with mechanical heart valve replacement

   • Sheng-Lan Tan
   • Zhi Li
   • Hong-Hao Zhou

   Pharmacogenetics 16 August 2013 Pages: 1769 - 1775

   

6. Influence of chronic hepatitis C infection on cytochrome P450 3a4 activity using midazolam as an in vivo probe substrate

   • P. N. Morcos
   • S. A. Moreira
   • P. F. Smith

   Pharmacokinetics and Disposition 14 June 2013 Pages: 1777 - 1784

   

7. Interaction of ambrisentan with clarithromycin and its modulation by polymorphic SLCO1B1

   • Christoph Markert
   • Regina Hellwig
   • Walter E. Haefeli

   Pharmacokinetics and Disposition 09 June 2013 Pages: 1785 - 1793

   

8. Concentration effect relationship of CYP3A inhibition by ritonavir in humans

   • Christine Eichbaum
   • Marianna Cortese
   • Gerd Mikus

   Pharmacokinetics and Disposition 09 June 2013 Pages: 1795 - 1800

   

9. A pharmacokinetic interaction study of ticagrelor and digoxin in healthy volunteers

   • Renli Teng
   • Kathleen Butler

   Pharmacokinetics and Disposition 09 June 2013 Pages: 1801 - 1808

   

10. Meta-analyses of dose-exposure relationships for gabapentin following oral administration of gabapentin and gabapentin enacarbil

    • Chao Chen

    Pharmacokinetics and Disposition 07 June 2013 Pages: 1809 - 1817

    

11. Spontaneous reporting of serious cutaneous reactions with protein kinase inhibitors

    • Emmanuelle Faye
    • Emmanuelle Bondon-Guitton
    • The French Network of Regional Pharmacovigilance Centers

    Pharmacoepidemiology and Prescription 09 June 2013 Pages: 1819 - 1826

    

12. Associations between generic substitution and patients' attitudes, beliefs and experiences

    • Jette Rathe
    • Pia Larsen
    • Jens Soendergaard

    Pharmacoepidemiology and Prescription 14 June 2013 Pages: 1827 - 1836

    

13. Adherence to hospital drug formularies and cost of drugs in hospitals in Denmark

    • Hanne T. Plet
    • Jesper Hallas
    • Lene J. Kjeldsen

    Pharmacoepidemiology and Prescription 14 June 2013 Pages: 1837 - 1843

    

14. Compliance with quality prescribing indicators in terms of their relationship to financial incentives

    • Rocío Fernández Urrusuno
    • Ma Carmen Montero Balosa
    • Beatriz Pascual de la Pisa

    Pharmacoepidemiology and Prescription 07 June 2013 Pages: 1845 - 1853

15. Statins are associated with reduced risk of gastric cancer: A meta-analysis

    • Xiao-Dan Wu
    • Kai Zeng
    • Yan-Qing Chen

    Pharmacoepidemiology and Prescription 09 June 2013 Pages: 1855 - 1860

    

16. Pharmacokinetic interaction between tacrolimus and berberine in a child with idiopathic nephrotic syndrome

    • Qian Hou
    • Weidong Han
    • Xiaobing Fu

    Letter to the Editors 14 June 2013 Pages: 1861 - 1862